| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |